Last reviewed · How we verify
Topical Chlorhexidine, 4%
Topical Chlorhexidine, 4% is a Small molecule drug developed by VA Office of Research and Development. It is currently FDA-approved.
Topical Chlorhexidine is a small molecule antiseptic used to reduce bacterial load on the ocular surface before cataract surgery. It has been studied in various clinical trials for conditions such as neonatal sepsis, omphalitis, and conjunctiva-related issues, among others.
At a glance
| Generic name | Topical Chlorhexidine, 4% |
|---|---|
| Sponsor | VA Office of Research and Development |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients (PHASE4)
- Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine (PHASE4)
- Bacterial Decolonization Plus Intraoperative Angiography for Soft Tissue Sarcomas Receiving Preoperative Radiotherapy (CONCERTO) (PHASE2)
- Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease (PHASE4)
- The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal (PHASE3)
- Decolonization to Reduce After-Surgery Events of Surgical Site Infection (PHASE4)
- A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection (PHASE3)
- A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical Chlorhexidine, 4% CI brief — competitive landscape report
- Topical Chlorhexidine, 4% updates RSS · CI watch RSS
- VA Office of Research and Development portfolio CI
Frequently asked questions about Topical Chlorhexidine, 4%
What is Topical Chlorhexidine, 4%?
Who makes Topical Chlorhexidine, 4%?
What development phase is Topical Chlorhexidine, 4% in?
Related
- Manufacturer: VA Office of Research and Development — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing